OEM News

Octagos Health Gains Over $43 Million Investment to Advance AI-Driven Cardiac Device Monitoring

The Series B investment was led by Morgan Stanley Expansion Capital and will go towards Atlas AI.

Octagos Health, an industry-leading provider of AI-driven cardiac device monitoring solutions, has raised over $43 million in investment capital in a Series B investment round. This round was led by Morgan Stanley Expansion Capital, with continued participation from Mucker Capital and other strategic investors. 
 
This funding will accelerate Octagos Health’s AI-driven platform that offers continuous monitoring and data analysis for patients with cardiac devices (pacemakers, defibrillators, ambulatory monitors, consumer wearables, and other modalities).
 
“By combining AI, patient services, and bidirectional EHR integration, the Octagos Health platform enables cardiologists to efficiently monitor patients, improve patient care, and enhance clinic economics. The funding will help us accelerate our growth across the US and expand into other critical areas of cardiac care, including ambulatory monitors, consumer wearables, and sleep.  Our goal is to build a comprehensive AI-based clinical decision support engine for healthcare. We are thrilled to have Morgan Stanley Expansion Capital as our lead investor and the continued support of Mucker Capital. In a short period, we have grown from first servicing my cardiology clinic to becoming one of the largest cardiac remote monitoring companies that provides software and services,” said Dr. Shanti Bansal, cardiologist, and CEO of Octagos Health and Houston Heart Rhythm.
 
The company’s proprietary technology, Atlas AI, ensures high accuracy and sensitivity in detecting clinically relevant events, automating physician workflows, and enabling healthcare providers to make informed decisions and improve patient outcomes. The platform’s comprehensive capabilities include seamless integration with electronic health records (EHR) and customizable reporting features, making it a preferred choice for cardiology practices.
 
“This investment will enable us to accelerate enhancements to our platform, in addition to scaling our commercial team and operations. We are currently the only company that helps cardiology practices migrate their historical data from legacy software providers and fully integrates with any EHR system. We do this while enabling customized reporting supported by patient and practice decision-support analytics,” said Eric Olsen, COO of Octagos Health. 

 

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters